Loading...
Boosting NAD(+) for the prevention and treatment of liver cancer
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide yet has limited therapeutic options. We recently demonstrated that inhibition of de novo nicotinamide adenine dinucleotide (NAD(+)) synthesis is responsible for DNA damage, thereby initiating hepatocarcinogenesis. We...
Na minha lista:
| Udgivet i: | Mol Cell Oncol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905329/ https://ncbi.nlm.nih.gov/pubmed/27308492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2014.1001199 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|